Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 6 Lung Neoplasms 5 Glioblastoma 4 Urinary Bladder Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Brain Neoplasms 3 Pancreatic Neoplasms 2 Lung Diseases 2 Glioma 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Tuberculosis, Pulmonary 1 Thyroid Nodule 1 Stomach Neoplasms 1 Solitary Pulmonary Nodule 1 Pulmonary Fibrosis 1 Pulmonary Embolism 1 Pulmonary Disease, Chronic Obstructive 1 Pulmonary Arterial Hypertension 1 Prostatic Neoplasms 1 Pleural Neoplasms 1 Pancreatic Cyst 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Multiple Pulmonary Nodules 1 Mouth Neoplasms 1 Mesothelioma 1 Medication Adherence 1

Interventions

Sunitinib 145 Nivolumab 144 pembrolizumab 132 Sorafenib 84 Bevacizumab 77 Everolimus 74 cabozantinib 71 pazopanib 65 Axitinib 65 Ipilimumab 62 aldesleukin 52 Magnetic Resonance Spectroscopy 45 Cyclophosphamide 40 Interleukin-2 38 lenvatinib 37 Specimen Handling 36 Radiosurgery 36 Interferon-alpha 32 atezolizumab 30 temsirolimus 27 belzutifan 24 Gemcitabine 23 fludarabine phosphate 22 avelumab 22 Radiotherapy 19 Interferon alpha-2 19 Biopsy 18 fludarabine 17 durvalumab 17 Nephrectomy 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Drug Delivery Systems × Clear all

NCT01967407 2014-11-19

IRENE

University of Magdeburg

Phase 1/2 Unknown

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡